Biocon Limited Biocon Limited

Biocon Limited

BIOCON

Kedudukan dalam Saham #3387
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Harga Saham
$3.76
Modal Pasaran
$5.14B
Perubahan (1 hari)
-2.11%
Perubahan (1 tahun)
-7.08%
Negara
IN
Perdagangan Biocon Limited (BIOCON)

Kategori

Healthcare
EPS untuk Biocon Limited (BIOCON)
EPS setakat June 2026 TTM: $0.04
Menurut laporan kewangan terkini dan harga saham Biocon Limited, EPS semasa syarikat (TTM) adalah $0.04. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $0.10 peningkatan berbanding EPS tahun 2023 iaitu $0.05.
Sejarah EPS untuk Biocon Limited dari 2004 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $0.04 -62.50%
2025 $0.10 -3.51%
2024 $0.10 117.16%
2023 $0.05 -34.17%
2022 $0.07 -15.85%
2021 $0.09 1.55%
2020 $0.08 -23.87%
2019 $0.11 127.22%
2018 $0.05 -39.53%
2017 $0.08 13.76%
2016 $0.07 6.33%
2015 $0.07 12.95%
2014 $0.06 -26.35%
2013 $0.08 40.32%
2012 $0.06 -19.09%
2011 $0.07 25.58%
2010 $0.06 249.38%
2009 $0.02 -84.00%
2008 $0.10 142.13%
2007 $0.04 21.11%
2006 $0.03 -14.32%
2005 $0.04 27.16%
2004 $0.03 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 46,086.67%
US
$-7.98 -21,380.00%
US
$-5.29 -14,206.67%
AU
- -
CH
$27.74 73,873.33%
NL